Lebrikizumab Found Effective for Patients With AD, SOC : vim

Interim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI.

Related Keywords

United States , New York , Miami , Florida , American , Eli Lilly , Andrew Alexis , Jills Waibel , Department Of Dermatology , American Academy Of Dermatology , Drug Administration , Eczema Area , Severity Index , American Academy , African American , American Indian , Alaska Native , Native Hawaiian , Global Assessment , Pruritus Numerical Rating Scale , Weill Cornell Medicine , New York City ,